Safety and Tolerability of HTI-1066 in Subjects With Advanced Solid Tumors

Clinical trial NCT03398720 · UNKNOWN

Trial details

NCT number: NCT03398720
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2017-12-31
Primary completion: 2018-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.